Johnson & Johnson has completed its $850 million acquisition of Proteologix, a biologics company that specializes in developing treatments for immune-mediated diseases, it announced June 21.

Counterfeit versions of Eli Lilly's blockbuster GLP-1 anti-obesity medications Mounjaro and Zepound are under fire from the drugmaker as it intensifies legal efforts to combat fraudulent and off-label cosmetic uses.

Walgreens is on a mission to attain provider status for its pharmacists. 

As pharmacies trim operating hours, Madison, Wis.-based UW Health is improving convenience and increasing access with medication kiosks. 

Individuals with health insurance are more likely to spend less on generic drugs when using their benefits compared to going through Mark Cuban's Cost Plus Drug Company, according to a study published June 14 in JAMA Health Forum.

Antibiotics currently in the clinical pipeline are still "inefficient" against the increasing prevalence of antimicrobial resistance, according to the World Health Organization's 2023 report on antibacterial agents in clinical and preclinical development, published June 14.

Medicare beneficiaries can now enroll in Amazon Pharmacy's RxPass medication prescription service, an Amazon Prime member benefit that offers access to dozens of commonly prescribed medications for $5 a month. 

The FDA has placed clinical holds on three trials run by Zentalis Pharmaceuticals after two study participants died, the biopharmaceutical company said June 18. 

Since 2020, drug shortage durations have increased by one year, with the average shortage lasting 3.3 years, according to U.S. Pharmacopoeia.

Spending on drugs purchased at discounted 340B prices across all participating facilities went up 19% annually between 2010 and 2021, according to a June 17 report from the Congressional Budget Office.